Hammer, Helen
Schmidt, Felix
Marx-Stoelting, Philip
Pötz, Oliver
Braeuning, Albert http://orcid.org/0000-0003-3810-027X
Funding for this research was provided by:
Bundesinstitut für Risikobewertung (1322-499)
Bundesinstitut für Risikobewertung (BfR)
Article History
Received: 4 August 2020
Accepted: 20 October 2020
First Online: 4 November 2020
Compliance with ethical standards
:
: The authors declare the following competing financial interest(s): O.P. is shareholder of SIGNATOPE GmbH. SIGNATOPE offers assay development and service using MS-based immunoassay technology.
: Not applicable.
: Not applicable.
: Not applicable.